Barr To Pay $142M To Settle Patent Dispute With Organon
U.S. drug maker Barr Pharmaceuticals will pay Dutch rival Organon International $142 million to settle a patent lawsuit over a generic version of the oral contraceptive Mircette....To view the full article, register now.
Already a subscriber? Click here to view full article